Investing Center Preview – Manage your investments and watch your net worth grow.
JSPR:NASDAQ – Small Cap Stock (Biotechnology)
Jasper Therapeutics Inc – JSPR Stock Overview
Last Price | Today's Change | 52-Week Range | Trading Volume |
---|---|---|---|
4.17 | 0.03 (+0.72%) | 4.05 - 30.70 | 42.1 thousand (Below Avg) |
Market data as of 11:18AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - JSPR
Open | 4.08 |
---|---|
Previous Close | 4.14 |
Day's Range | 4.05 - 4.19 |
Market Cap | 62.6M |
Avg Volume (10 Day) | 191.8K |
Price/Earnings (Trailing 12 Mo.) | -- |
Earnings Per Share (Trailing 12 Mo.) | -4.2738 |
Dividend Yield | No Dividend |
One-Click Scorecard - JSPR


These seven metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Performed well consistently? | Fail |
---|---|
Avoids excess debt? | Fail |
Converting sales to profits? | Fail |
Shareholder's money handled rationally? | Neutral |
Increased shareholder value? | Neutral |
Consistently increased owner earnings? | Fail |
Sells at 25% discount to intrinsic value? | Fail |


These eight metrics are a snap to calculate, thanks to Quicken.com's One-Click Scorecard. Our goal with this tool is to help you evaluate potential investment candidates and eliminate those equities that aren't up to snuff. One-Click Scorecard won't do all the homework necessary for you to reach a decision, but it will help you develop a list of quality stocks to watch and study further.
Pays a cash dividend? | Neutral |
---|---|
Room to increase dividends? | Fail |
Increased earnings over time? | Neutral |
Borrows within reasonable limits? | Pass |
Stock is undervalued? | Fail |
Have investors caught on? | Pass |
Has support of institutional investors? | Fail |
Has sufficient liquidity? | Pass |
Latest Headlines - JSPR
No news headlines available for JSPR
Industry Position - JSPR
JSPR | Industry Range | |
---|---|---|
Revenue Growth (1yr) | 0.00% | |
Net Income Growth (1yr) | -- | |
Total Debt/Equity | 0.03 | |
LT Debt/Equity | 0.01 | |
Earnings Yield | -- | |
Price/Sales | -- |
Competitors - JSPR
Company | Last | Change |
---|---|---|
MedMira Inc | 0.10 | 0.00% |
0.57 | 0.00% | |
Corbus Pharmaceuticals Holdings Inc | 5.18 | +2.88% |
Acumen Pharmaceuticals Inc | 1.06 | -1.86% |
Cabaletta Bio Inc | 1.21 | +3.42% |
Data is delayed by at least 15 min.